Can circulating miR-7-1-5p, and miR-33a-5p be used as markers of T2D patients?
- 21 January 2021
- journal article
- research article
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 129 (3) , 771-777
Abstract
Recent evidence has indicated that miRNAs play an important role in both initiation and progression of many pathologic processes such as diabetes and can be used as an important and more sensitive ...Keywords
Funding Information
- ShahidBeheshti University of Medical Science
- Shahid Beheshti Deputy of Research Affairs
This publication has 27 references indexed in Scilit:
- Diabetes mellitus: The epidemic of the centuryWorld Journal of Diabetes, 2015
- Influence of miRNA in insulin signaling pathway and insulin resistance: micro‐molecules with a major role in type‐2 diabetesWIREs RNA, 2014
- Pharmacological Inhibition of a MicroRNA Family in Nonhuman Primates by a Seed-Targeting 8-Mer AntimiRScience Translational Medicine, 2013
- Circulating microRNAs as novel biomarkers for diabetes mellitusNature Reviews Endocrinology, 2013
- Prediabetes: a high-risk state for diabetes developmentThe Lancet, 2012
- Regulation of Pancreatic microRNA-7 ExpressionExperimental Diabetes Research, 2012
- Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglyceridesNature, 2011
- miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signalingProceedings of the National Academy of Sciences, 2011
- MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 ( Srebp2 ) regulates HDL in vivoProceedings of the National Academy of Sciences, 2010
- MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreasGene Expression Patterns, 2009